Skip to main content
Fig. 3 | Virology Journal

Fig. 3

From: Immunogenicity of adenovirus-vector vaccine targeting hepatitis B virus: non-clinical safety assessment in non-human primates

Fig. 3

Serum antibody titer levels following multiple administrations (day 1, 8, 15, 22, 29, 36, and 43) up to day 68 post-injection. The cut-off titer value was 1:100. Antibody titers of each group are respectively shown as purple (Ad5-null control), green (high-dose group), red (mid-dose group), and blue (low-dose group) curves. Antibody titers were compared using a non-parametric test (Friedman’s test with Dunn’s multiple comparisons test); ** p value < 0.01

Back to article page